Helpdesk

Sales contact

Home > Resources > Interview mode: a valuable data collection alternative supporting Decentralized Clinical Trials

Interview mode: a valuable data collection alternative supporting Decentralized Clinical Trials

Last updated: July 19, 2024

Collecting ePRO & eObsRO data via interview mode can be recommended in specific circumstances, according to the medical conditions, operational situations, or study design specificities. Discover the key advantages of the Kayentis interview mode:

Subscribe to our newsletter

Better Raters,Smarter eCOA,Stronger Data

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical...

Kayentis and RWS join forces to improve data confidence in...

What if eCOA could elevate your next rare disease trial?

Elevating rare disease clinical trials through eCOA – From patient...

Overcoming rare disease trial challenges: the strategic impact of eCOA

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events